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Supplementary Figure 1.  Flow cytometry study gating strategy.  Cells were 
gated according to morphology side scatter (SSC-A) vs forward scatter (FSC-A).  
Doublets were excluded (FSC-A vs FSC-H and SSC-A vs SSC-H).  Live cells 
were selected using the viability dye. Flow cytometry density plots showing 
gating strategy used to identify CD11c+CD88+CD317+ cells 
(CD45+MHCII+D11c+CD88+CD317+), B cells (CD45+CD3-CD19+), CD4+ T cells 
(CD45+CD3+CD4+) and CD8+ T cells (CD45+CD3+CD8+).  Each sample contains 


















Supplementary Figure 2.  The composition of leukocytes outside the CD11c+ 
lineage is not altered in CD11c.Cre+/-ITGA4fl/fl mice.  The mean ± standard 
deviation (SD) of leukocyte subsets (%) from total 50 x 103 recorded viable cells 
in different compartments, including (A-F) brain and spinal cord, (G-L) spleen 
and lymph node and (M-R) bone marrow and blood, is presented during naïve, 
acute and persistent clinical actively-induced experimental autoimmune 
encephalomyelitis (EAE) in CD11c.Cre+/-ITGA4fl/fl mice or C57BL/6 wild type 
(WT) controls (N =6 experimental animals per group; data show pooled analysis 
of all study cohorts).  There was no difference in frequency of cell types including 
CD45+, CD19+, CD4+ and CD8+ cells between the two groups during different 





















Supplementary Figure 3: Characterization of CD11c+CD88+CD317+ cells and 
microglia using ex vivo flow cytometry. (A) CD45hi cells were not abundantly 
present in naïve CNS tissue.  (B) From CD45+ cells, (C) CD11c+MHCII+ and (D) 
CD88+CD317+ cells were selected.  Next, (E) CX3CR1+ cells were gated for, and 
selected for (F) expression of TMEM119+ or (J) the absent expression of 
TMEM119-.  (G) Iba-1+ cells were selected from TMEM119+cells.  (H, R) The 
majority of CX3CR1+TMEM119+Iba-1+ cells defined as parenchymal microglia 
localized in the CD45int gate.  (K) Iba-1- cells were selected from TMEM119-cells.  
(L, S) The majority of CX3CR1+TMEM119-Iba-1- cells defined as non-microglia 
localized in the CD45hi gate.  (I) FewerCD45int microglia expressed CD86 
compared to (M) CD45hi non-microglia.  (O, N) CD45+CD11c+CD88+ cells in the 
blood were mostly (P) CX3CR1+, but (Q) TMEM-119- and Iba-1- . 
 
 
